Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Insecticides India Ltd. Earnings Release 2025

May 28, 2025

59336_rns_2025-05-28_f5be37ff-416e-4378-a8b5-eb48fa128fd9.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Ref: IIL/SE/2025/2805/01 Date: May 28, 2025

The Manager
Listing Compliance Department Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
(Through BSE Listing Centre) (Through NEAPS)
Scrip Code: 532851 Symbol: INSECTICID

Dear Sir/Madam,

Re: Outcome of the Board Meeting

This has reference to our letter no.: IIL/SE/2025/2403/01 dated March 24, 2025.

The Board of Directors of the Insecticides (India) Limited/the Company ("Board") at their meeting held today i.e May 28, 2025 inter alia transacted the following business:

    1. Considered and approved the Audited Standalone and Consolidated Financial Results of the Company, for the Quarter and Year ended March 31, 2025 along with Auditor's Report based upon unmodified opinion of M/s S S Kothari Mehta & Co., LLP and M/s Devesh Parekh & Co., Joint Statutory Auditor(s) of the Company on the Financial Statements. The Financial Results were reviewed and recommended by the Audit Committee. Accordingly, we enclosed the following as Annexure:
  • Audited Standalone and Consolidated financial results and Audited Standalone and Consolidated financial statements for the financial year ended March 31, 2025.
  • Auditor's Report issued on the Financial Results.
  • A Declaration from the CFO as required pursuant to Regulation 33(3) of the Listing Regulations, regarding unmodified opinion of the Statutory Auditors on the Financial Results.

A copy of the said results together with the Auditor's report are also being made available on the website of the Company at www.insecticidesindia.com.

    1. The 28th Annual General Meeting (AGM) of the Company will be held on Tuesday, August 12, 2025 at 03:00 PM through Video Conferencing ("VC").
    1. On the recommendation of the Audit Committee, appointment of M/s. Akash Gupta & Associates, Company Secretaries (PCS Registration No. 11038), as Secretarial Auditor of the Company for a period of five consecutive years commencing from financial year 2025-26 till financial year 2029-30, subject to approval of members at the ensuing 28th

AGM. Details in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 are enclosed.

The Board meeting commenced at 02:00 PM (IST) and concluded at 03:30 PM (IST)

You are requested to kindly take on records.

Thanking You, For Insecticides (India) Limited

SANDEEP KUMAR Digitally signed by SANDEEP KUMAR Date: 2025.05.28 15:31:45 +05'30'

(Sandeep Kumar) Company Secretary & CCO

Encl: As above

CIN: L6599 IDL l996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 11 0 033;

Telefax.: 0 11-27679700 - 05; Website: www.insecticidesindia.com; E-mail: [email protected] - STATEMENT OF STANDALONE AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2025

(~ In lacs, except EPS)
Quarter Ended Year Ended
SI No. Particulars 31-03-2025 31-12-2024 31-03-2024 31-03-2025 31-03-2024
(Audited (Unaudited1 (Audited) (Audited (Audited
I Revenue from operations 35,914.5) 35,922.71 27,250.21 2,00,226.58 1,96,638.55
II Other Income 293.54 20.92 455.82 722.58 950.67
Ill Total Lncome (l+11) 36,208.05 35,943.63 27,706.03 2,00,949.16 1,97,589.22
IV Expenses
(a) Cost of materials consumed
(b) Purchase of Stock-in-Trade
32,731.06 23,937.05 27,010.22 1,35,514.02 1,33,2 19.31
(c) Changes in inventories of finished goods, work-in-progress and stock- 1,219.55 2,095.11 766.06 7,511.27 15,885.66
in-trade ( 11,099.52) (2,744.08) (9,210.44) (6,389.16) (2,602.36)
( d) Employee benefits expense 2,815.28 3,211.15 2,569.14 13,715.70 11,722.13
(e) Finance costs 201.77 140.38 206.95 672.32 1,088.35
( f) Depreciation and an1ortization expense 713.62 754.98 759.85 2,904.75 2,924.85
(g) Other expenses 7,401.16 6,555.45 5,189.21 27,991.77 22,093.29
Total expenses 33,982.92 33,950.04 27,290.99 J,81,920.67 1,84,331.23
V Profit before tax (Ill-IV) 2,225.13 1,993.59 415.04 19,028.49 13,257.99
VI Tax Expense
(1) Current Tax 1,222.43 508.59 ( 150.27) 5,539.15 3,295.17
(2) Deferred Tax (399.79' (15.14) (242.61) (487.22) (299.73)
Total Tax Expense 822.64 493.45 (392.88) 5,051.93 2,995.44
vu Profit for the period/year (V-Vl) 1,402.49 1,500.14 807.92 13,976.56 10,262.55
VIII Other comprehensive income I
Items that will not be reclassified to profit or loss
(i) Changes in fair value of FVTOCJ equity instruments 31.26 (90.09) 111.36 (30.71) 221.09
(ii) Remeasurement of net defined benefit plans (135.77) (1.25) 56.46 (139.52) (3.54)
(iii) income tax relating to these items 26.88 21.30 (40.15; 42.26 (50.61)
Other comprehensive income for the period/ year (net of tax) (77.63; (70.04) 127.67 {127.971 166.94
IX Total comprehensive income for the period/ year (Vll+VIII) 1,324.86 1,430.10 935.59 13,848.59 10,429.49
Paid up equity share capital (Face value '{ I 0/- each) 2,909.78 2,909.78 2,959.78 2,909.78 2,959.78
Other Equity - - - 1,05,269.25 98,150.64
Earnings per share (of no each)
(a) Basic 4.82 5.15 2.73 47.61 34.67
(b) Diluted 4.82 5.15 2.73 47.61 34.67
(Note: EPS for respective quarters are not annualized)

Notes:

~

  • I The above Audited Standalone Financial Results have been published in accordance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 28, 2025. The auditors of the company have carried out the audit of the same. The Audit Report along with Financial Results for the quarter and year ended March 31, 2025 are available on the Stock Exchanges website at www.bseindia.com, www.nseindia.com and on the Company's website www.insecticidesindia.com
  • 2 The above Audited Financial Results have been prepared in accordance with the Indian Accounting Standard (Ind AS), the provisions of the Companies Act, 2013 ("the Act"), as applicable and guidelines issued by the Securities and Exchange Board of India ("SEBI"). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 20 15 and subsequent amendments thereto.

  • 3 The Company is in the business of manufacturing and distribution of Agro-Chemicals and accordingly has one business segment viz "Agro-Chemicals" comprising of Technical & Formulation.

  • 4 The Board of Directors of the Company at its meeting held on August 30, 2024, approved Buyback of 5,00,000 fully paid-up equity shares of face value of ~ 10/· each at a price of~ I 000/- per equity share (being 1.69% of the total paid up equity capital of the Company) for an aggregate consideration not exceeding ~ 5,000 Lacs (excluding transaction cost and any other expenses incurred for the buy back) representing 4.97% and 4.96% of the aggregate of the paid up share capital and free reserves (including securities premium) as per the audited standalone and consolidated financial statements respectively as on March 31, 2024. Further, on the settlement date i.e. September 30, 2024, Company has made payment of t 5,000 Lacs to those shareholders of securities whose offer has been accepted. The issued capital of the Company pre-buyback was 2,95,97,837 and post-buyback is 2,90,97,837. However, as on September 30, 2024, the number o shares remain 2,95,97,837 as the same were ex'tinguished on October 05, 2024. ln accordance with section 69 of the Companies Act, 2013, the Company bas created 'Capital Redemption Reserve' of~ 50 Lacs equal to the nominal value of the shares bought back as an appropriation from general reserve.
  • 5 The Board of Directors of Insecticides (India) Limited at its meeting held on August 09, 2024 had approved the dissolution/ liquidation of its wholly owned subsidiary !IL Overseas DMCC, Dubai. Accordingly, llL Overseas DMCC has filed the application for windup / dissolution with DMCCA (Office of the Registrar of Companies of Dubai Multi Commodities Centre Authority) for which approval is yet to be received as of March 31 , 2025.
  • 6 The Board of Directors of the Company, at its meeting held on November 11 , 2024, approved the acquisition of I 00% equity shares of 'Kaeros Research Private Limited' ("Target Company") from its existing shareholders through a share purchase agreement ("SPA") between the existing shareholders and the Company. Consequently, target company becomes the wholly owned subsidiary of Insecticides (India) Limited.
  • 7 The figures of the last quarter are the balancing figures between audited figures in respect of the full financial year up to 31 March 2025 and the unaudited published year-to-date figures up to 31 December 2024 being the date of the end of the third quarter of the financial year which were subjected to a limited review.

Fo on behalf of the Board

{ Ra '! anaging Director DJN : 00576872

Place: Delhi Date: May 28, 2025

CIN: L6599 I DL I 996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 110 033; Telefax.: 011-27679700 - 05; Website: www.insecticidesindia.com; E-mail: [email protected] STATEMENT OF STANDALONE AUDITED BALANCE SHEET AS AT MARCH 31, 2025

(( !11 lacs)
S. No Particulars As at 31-03-2025 As at 31-03-2024
ASSETS
(I) Non-current assets
(a) Property, plant and equipment 22,981.29 23,672.28
(b) Capital work-in-progress 15,599.24 13,468.73
(c) Investment properties 104.67 109.47
(d) Right-of-use assets 3,904.01 3,844.10
(e) Other Intangible assets 852.75 704.17
(t) Intangible assets under development 498.54 642.37
(g) Investment in subsidiaries and jointly controlled entity 1,823.56 1,006.13
(h) Financial assets
(i) Investments 822.18 852.89
(ii) Other financial assets 267.32 341.38
(i) Income tax assets (net) 132.72 683 .85
U) Other non-current assets 604.65 930.24
Total non-current assets 47,590.93 46,255.61
(2) (a) Current assets
Inventories
88,268.01 80,646.03
(b) Financial assets
(i) Trade receivables 38,567.91 29,666.82
(ii) Cash and cash equivalents 5,538.01 6,105.27
(iii) Bank balances other than (ii) above 118.11 15.83
(iv) Loans 25.01 14.39
(v) Other financial assets 851.47 247.77
(c) Other current assets 7,800.52 8,023.97
Total current assets 1,41,169.04 1,24, 720.08
Total assets 1,88,759.97 1,70,975.69
EQUITY AND LIABILITIES
EQUITY
(a) Equity share capital 2,909.78 2,959.18
(b) Other equity 1,05,269.2S 98,150.64
Total equity 1,08,179.03 1,01,110.42
LIABILITIES
(I) on-current liabilities
(a) Financial liabilities
(i) Borrowings 2,347.24 2,917.16
(ii) Lease liabilities 264.60 231.35
(b) Provisions 544.60 218.42
(c) Deferred tax liabilities (Net) 486.63 1,016.11
Total non-current liabilities 3,643.07 4,383.04
Current lia bilities I•
(2) (a) Financial liabilities
(i) Borrowings 7,551.74 5,402.73
(ii) Lease liabilities 239.54 179.70
(iii) Trade Payables
(A) total outstanding due of micro enterprises and small 2,250.29
enterprises; and 1,724.30
(8) total outstanding dues of creditors other than micro 47,777.29 40,124.29
enterprises and small enterprises. 11
(iv) Other financial liabilities 4,699.45 3,376.13
(b) Other current liabilities 13,055.91 14,263.87
(c) Provisions 483.59 411.21
(d) Current tax liabilities (Net) 880.06
Total current liabilities 76,937.87 65,482.23
Total eouitv and liabilities 1,88, 759.97 I, 70,975.69

Place: Delhi Date: May 28, 2025 ES For and on beh If o e Board o Directors loo() (l,i., nsectic, es ~lndi Limited

1,

~ Rajesh Ku a r Aggarwal "*DEL\°\* M ging Director DIN : 00576872

CfN: L6599 l DLI 996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 11 0 033; ,~-- Telefax.: OJ 1-27679700 - 05; Website: www.insecticidesindia.com; E-mail: investor@ insecticidesindia.com STANDALONE AUDITED STATEMENT OF CASH FLOW FOR THE YEAR ENDED MARCH 31, 2025

(r In lacs)
Pa rticula rs 31-03-2025 31 -03-2024
(A) Cash Flow Fr om Operating Activities
Profit before tax 19,028.49 13,257.99
Adjustment on account of
- Depreciation 2,904.75 2,924.85
- (Profit)/ Loss on sale of property, plant & equipment (19.09) ( 173.23)
- Net gain on lease modification -
- Interest income (0.27)
- Dividend income (235.45)
(22.83)
(52.85)
- Interest expenses (22.05)
- Bad debtS written off 672.32 1,088.35
- Loss Allowance on Advances 29.26 22.76
- Impairment expenses on investment 217.83
- Provision for impainnent of trade receivables 6.84
- Derivative (gain)/ loss 554.65 272.20
- Unrealised exchange differences 305.42
(290.12
23.64
Operating Profit Before Working Capital Changes 23,152.07 (153.98)
Adjustments for I 7,187.41
- (Increase )/Decrease in security deposits (30.54)
- (lncrease)/Decrease in inventories (7,621.98) (37.26)
- (lncrease)/Decrease in trade receivables (9,434.30) 5,526.04
- (Increase)/Decrease in loans (10.62) (253.67)
- (Increase)/Decrease in other financial assets (763.76) 4.84
- (lncrease)/Decrease in other current assets 400.55 ( 179.55)
(2,663.72)
- lncrease/(Decrease) in provisions 259.04 194.50
- lncrease/(Decrease) in trade payables 8,471.01 (2,852.06)
- lncrease/(Decrease) in other financial liabilities 356.62 474.10
- Increase/(Decrease) in other current liabilities (1,207.97 2,404.89
Cash generated from operations 13,570.12 19,805.52
Less: Income tax paid (4,107.96 (1,350.19'
Net cash flow (used in) / from ooer atin11 activities (A) -
9,462.16
18,455.33
(B) Cash Flow From Investing Activities
- Purchase of property, plant and equipment and intangible assets, capital-work-in-progress and
intangible assets under development (3,568.61) (4,903.62)
- Proceeds from sale of property plant and equipment 261.87 536.97
- Interest received 235.45 52.85
- Proceeds from / (investment in) bank deposits (net) 2.32 (7.79)
- Dividends received 22.18 20.58
- Investment in eauity shares of subsidiarv comoanv (824.27 (82.00)
Net cash flow (used in)/ from lnvestin" Activities (8) (3,871.06) (4,383.01)
(C) Cash Flow From Fina ncing Activities
- Repayment due to Buyback of equity shares including premium, expenses & taxes (6,188.02)
- Repayment of non-current borrowings (1,331.12) (1,794.09)
- Proceeds from non-current borrowings 708.59 4,470.23
- Proceeds/(Repayment) from/of current borrowings 2, 149.01 (10,3 18.30)
- Payment of lease liabilities (220.41) (178.99)
- Interest paid (684.45) (1,096.27)
- Dividend paid (Final & Interim) (591.96' (887.94
Net cash flow (used in)/ from linancin" a
ctivities (C)
(6,158.36] (9,805.36
Net increase/ (decr ease) in Cash and Cash Equivalents (A+B+C)
Cash and Cash Eauivalents at the beginning of the vear (567.26) 4,266.96
Cash and Cash Ea uivaleots at the end of the year 6,105.27 1,838.3 1
5,538.01 6,105.27

For and on behalf of the Board of Directors s O ",;~~ ...... ,

<Jl ()"-1 Ra .·es bumar Aggan val Place: Delhi 1-c "*DEL\»\* anaging Director Date: May 28, 2025 DIN : 00576872

S S KOTHARI MEHTA & CO. LLP Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-Itr

Chartered Accountants 675, Aggarw al Cyb er Plaza'2,

Independent Auditor's Report on the Quarterly and Year ended Audited Standalone Financial Results of Insecticides (India) Limited Pursuant to Regulation 33 of the SEBI fl,'isting Obligation and Disclosure Requirements) Regulations, 2015, as amended

To The Board of Directors of Insecticides (India) Limited

Report on the audit of the Standalone Financial Results

Opinion

We have audited the accompanying standalone financial results of Insecticides (India) Limited (the ,,Company") for the quarter and year ended March 31,2025 ("Statement"), attached herewith, teing suUmitteiby the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obfiations and Disclosure niquirements) Regulations, 2015, as amended (the "Listing Regulations").

In our opinion and to the best of our information and according to the explanations given to us, the Statement:

  • i. is presented in accordance with the requirements of Regulation 33 of the Listing Regulations; and
  • ii. gives a true and fair view in conformity with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India ofthe net profit and other comprehensive income(loss) and other financial information of the company for the quarter and year ended March 31,2025.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Companies Act, 2013 (the Act). Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Standalone Financial Results' section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartired Accountants of India together with the ethical requirements thit are relevant to our audit of the financial statement under the provisions of the Cornpanies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the aujit evidelce we havc obtaincd is sufficient and appropriate to provide a basis fot'ottr opinion'

Management's Responsibilities for the standalone Financial Results

The Statement has been PrePared on the basis of the standalone financial statements' The Company 's Board of Directors are responsible for the preparation of the Statement that give a true and fair view of the net profit and other comprehensive income(loss) and other financial information in accordance with the recognition and measurement principles laid down in Indian Accounting Standards Prescribed under Seotion 133 of the Act read with relevant rules issued thereunder and other accounting principles generallY accepted in India and in compliance with Regulation 33of the Listing Regulations. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions ofthe Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other inegularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance internal

S S KOTHARI MEHTA & CO. LLP Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase'III

Chartered Accountants 675, Aggawval Cyber Plaza-2, Netaii Place- Pitamoura. 1I 0034 NewDelhi -1 10020

financial controls that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation ofthe Statement that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the Statement, the Board of Directors are responsible for assessing the Company's aUiiiryto continue as a going concern, disclosing, as applicable, matters related to going concern and using the going .oirrnibusis of accounting unless the Board of Directors either intends to liquidate*the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors are also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the Standalone X'inancial Results

Our objectives are to obtain reasonable assurance about whether the Statement as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is ahigh level ofassurance but is not a guarantee that an audit conducted in accordance with SAs will ilways detect a material misstatement when it exists. Misstatements can arise from fraud or eror and are considered material if, individually or in the aggregate, they could reasonably be expected to inJluence the economic decisions ofusers taken on the basis of these Statement.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  • r Identify and assess the risks of material misstatement of the Statement, whether due to fraud or e6or, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriati to provide a 6asis for our opinion. The risk ofnot detecting a materialmisstatement r"suiting from fraud is higher than for one resulting from error, as fraud may involve collusion, forger!, intentional omissions, misrepresentations, or the override of internal control.
  • . Obtain an understanding of intemal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible foi expressing our opinion on whether the Company has adequate internal financial control with refeience to financial statements in place and the operating effectiveness of such controls.
  • r Evaluate the appropriateness ofaccounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board ofDirectors.
  • . Conclude onthe appropriateness of the Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conciude that a material uncertainty exists, we afe required to draw attention in our auditor's report to the related disclosures in the financial results or, if such disclosures are inadequate, to modiff our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor'J report. However, future events or conditions may cause the Company to cease to continue as a goingconcern'
  • r Evaluate the overall preserrtation, structure and content of the Statement, including the disclosures, and whethir the Statement represent the underlying transactions and events in a manner that achieves fair presentation.

S S KOTHARI MEHTA & CO. LLP Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-III -l

Chartered Accountants 675, Aggarwal Cyber Plaza-2,

We communicate with those charged with govemance regarding among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identiff during our audit.

We also provide those charged with govemance with a statement that we have complied with relevant ithical requirements regarding independence, and to communicate with them all relationships and other matters thai may reasonably be thought to bear on our independence, and where applicable, related safeguards.

Other Matters

The Statement includes the results for the quarter ended March 31,2025, being the balancing figure between the audited figures in respect of the full financial year ended March 31,2025 and 111-9 published unaudited year -to-date figures up to the third quarter ofthe current financial year, whiitr were subjected to a limited review by us, as required under the Listing Regulations'

For S S Kothari Mehta & Co. LLP Chartered Accountants

Firm' s registration number: 000756N4I50044 1

a a vijay * Partner Membership number: *

UDIN : 2509267 7BMOFCF2879 Place: Delhi Date: May 28,2025

For Devesh Parekh & Co. Chartered Accountants Firm's registration number: 013338N

Partner Membership number: 527 873 UDIN : 25527 873BNUICA5557

Place: Delhi Date: May 28,2025

CIN: L65991DLI 996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 110 033;

,_ Telefax.: 01 1-27679700 - 05; Website: www.insecticidesindia.com; E-mail: [email protected] - STATEMENT OF AUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2025

(( In lacs, excevt EPS)
Quarter Ended Year Ended
SI No. Particulars 31-03-2025
(Audited)
31-12-2024
(Unaudited)
31-03-2024
(Audited)
Refer note 6
below
31-03-2025
(Audited)
31-03-2024
(Audited)
Refer note 6
below
I
II
Revenue from operations
Other lncome
35,892.05
285.55
35,770.47
15.50
27,250.21
450.96
1,99,994.96
699.55
1,96,638.55
939.91
Ill Total Income (1+11) 36,177.60 35,785.97 27,701.17 2,00,694.51 1,97,578.46
IV Expenses
(a) Cost of materials consumed
(b) Purchase of Stock-in-Trade
(c) Changes in inventories of finished goods, work-in-progress and stock
32,637.84
1,219.55
23,596.62
2,095. 11
27,015.61
766.06
1,34,837.66
7,5 I 1.27
1,33,224.70
15,885.66
in-trade (1 1,101.14) (2,839.94) (9,2 I 5.90) (6,436.78) (2,607.82)
( d) Employee benefits expense
(e) Finance costs
(f) Depreciation and amortization expense
(g) Other expenses
Total expenses
2,863.47
214.09
717.04
7,424.84
33,975.69
3,249.02
140.61
758.11
6,580.41
33,579.94
2,591.91
207.42
760.37
5,219.21
27,344.68
13,870.97
686.45
2,915.34
28,090.11
l ,81,475.02
11,745.18
1,088.83
2,925.37
22, 158.74
1,84,420.66
V
VI
Profit before tax, exceptional items and share of net profit of
investment accounted for using equity method (UI-rv)
Share of net profit of jointly controlled entity accounted for using the
2,201.91
0.42
2,206.03
22.13
356.49
(5.33)
19,219.49
57.45
13,157.80
31 .01
VII equity method
Profit Before Tax (V+VI)
2,202.33 2,228.16
VIII Tax Expense 351.16 19,276.94 13,188.81
( I) Current Tax
(2) Deferred Tax
Total Tax Expense
1,226.13
(412.91)
538.82
(47. 16)
( 150.27)
(250.66)
5,591.47
(516.391
3,295.17
(313.81'
813.22 491.66 (400.93] 5,075.08 2,981.36
IX Profit for the period/year (VII-VIII) 1,389.11 1,736.50 752.09 14,201.86 10,207.45
X Other comprehensive income
Items that will not be reclassified to profit or loss
(i) Changes in fair value ofFVTOCI equity instruments
(ii) Remeasurement of net defined benefit plans
31.26
(135.77)
(90.09)
( 1.25)
111.36
56.46
(30.7 1)
(139.52)
221.09
(3.54)
(iii) Share of Other comprehensive income of jointly controlled entity
accounted for using equity method
4.66 (4.3 1) 12.54 (8.26) I 1.85
(iv) Income tax relating to these items 25.72 22-38 (43.3 1) 44.35 (53.60)
Items that will be reclassified to profit or loss
(i) Exchange differences in translating the financial statements of
foreign operations
- (0.24) - (0.03) -
Other compr ehensive income for the period/year (net of tax) (74.13) (73.51) 137.0S (134.171 175.80
XI Total comprehensive income for the period/year (Xl+XID 1,314.98 1,662.99 889.14 14,067.69 10,383.25
Paid up equity share capital (Face value~ I 0/- each) 2,909.78 2,909.78 2,959.78 2,909.78 2,959.78
Other Equity - - - 1,05,549.60 98,211.89
Earnings per share (on'l0 each)
(a) Basic
(b) Diluted
(Note: EPS for respective quarters are not annualized)
4.77
4.77
5.96
5.96
2.54
2.54
48.38
48.38
34.49
34.49

'otcs:

  • The above Audited Consolidated Financial Results have been published in accordance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 20 15, as amended. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 28, 2025. The auditors of the company have carried out the audit of the same. The Audit Report along with Financial Results for the quaner and year ended March 31, 2025 are available on the Stock Exchanges website at www.bseindia.com, www.nseindia.com and on the Company's website www.insecticidesindia.com
  • 2 The above Audited Financial Results have been prepared in accordance with the Indian Accounting Standard (Ind AS}, the provisions of the Companies Act, 2013 ("the Act"), as applicable and guidelines issued by the Securities and Exchange Board of India ("SEBI"). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 20 I 5 and subsequent amendments thereto.
  • 3 The Company is in the business of manufacturing and distribution of Agro-Chemicals and accordingly has one business segment viz "Agro-Chemicals" comprising of Technical & Fonnulation.
  • 4 The Board of Directors of the Company at its meeting held on August 30, 2024, approved Buyback of 5,00,000 fully paid-up equity shares of face value of ~ I 0/ each at a price of~ I 000/- per equity share (being 1.69% of the total paid up equity capital of the Company) for an aggregate consideration not exceeding t 5,000 Lacs (excluding transaction cost and any other expenses incurred for the buy back) representing 4.97% and 4.96% of the aggregate of the paid up share capital and free reserves (including securities premium) as per the audited standalone and consolidated financial statements respectively as on March 31, 2024. Further, on the settlement date i.e. September 30, 2024, Company has made payment oft 5,000 Lacs to those shareholders of securities whose offer has been accepted. The issued capital of the Company pre-buyback was 2,95,97,837 and post-buyback is 2,90,97,837. The above were extinguished on October 05, 2024. In accordance with section 69 of the Companies Act, 2013, the Company has created 'Capital Redemption Reserve' of~ 50 Lacs equal to the nominal value of the shares bought back as an appropriation from general reserve.
  • 5 The Board of Directors of Insecticides (India) Limited at its meeting held on August 09, 2024 had approved the dissolution/ liquidation of its wholly owned subsidiary IIL Overseas DMCC, Dubai. Accordingly, IIL Overseas DMCC has filed the application for windup / dissolution with DMCCA (Office of the Registrar of Companies of Dubai Multi Commodities Centre Authority) for which approval is yet to be received as of March 3 I, 2025.
  • 6 TI1e Board of Directors of the Company, at its meeting held on November 11 , 2024, approved the acquisition of 100% equity shares of 'Kaeros Research Private Limited' ("Target Company") from its existing shareholders through a share purchase agreement ("SPA") between the existing shareholders and the Company. Consequently, target company becomes the wholly owned subsidiary of the Group. The transaction is considered as Common control transaction as per Ind AS 103. As per guidance on accounting for common control transactions contained in Ind AS I 03 "Business Combinations" the acquisition has been accounted for using the pooling of interest method. Accordingly, the consolidated financial statements of the Group have been restated with effect from April 01, 2023, by transferring all assets, liabilities and reserves of the target company, with the differential amount from the purchase consideration has been recognised in capital reserve (other equity). Therefore, the figures for the quarter and year ended March 3 I, 2024 have been restated.
  • 7 The figures of the last quaner are the balancing figures between audited figures in respect of the full financial year up to 3 1 March 2025 and the unaudited published year-to-date figures up to 3 I December 2024 being the date of the end of the third quaner of the financial year which were subjected to a limited review.

b:~• n,.,,

Rajesh umar Aggarwal naging Director DIN : 00S76872

Place: Delhi Dale: May 28, 2025

,_ Insecticides (India) Limited
ClN: L65991 DLI 996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - l lO 033;
Telefax.: OJ J-27679700 - 05; Website: www.insecticidesindia.com; E-mail: [email protected]
STATEMENT OF AUDITED CONSOLlDATED BALANCE SHEET AS AT MARCH JI_, 2025
S.No Particulars (i In lacs)
A• at 31-03-2025 As at 31-03-2024•
ASSETS
(1) Non-current assets
(a) Property, plant and equipment 23,119.88 23,728.90
(b) Capital work-in-progress 15,610.93 13,540.32
(c) Investment properties 299.15 303.95
(d)
(e)
Right-of-use assets
Other Intangible assets
3,904.01
863.40
3,844. 10
708.66
(I) Intangible assets under development 498.53 645.87
(g) Investment in jointly controlled entity 1,152.37 1,101.10
(h) Financial assets
(i) Investments 822.18 852.89
(ii) Other financial assets 267.60 341.48
(i) Income tax assets (net) 152.71 683.89
(j) Other non-current assets
Total non-current assets
617.01 930.24
47,307.77 46,681.40
(2) Current assets
(a) Inventories 88,624.54 80,738.28
(b) Financial assets
(i) Investments
(ii) Trade receivables
957.45
38,531.65
352.77
29,666.82
(iii) Cash and cash equivalents 5,592.70 6,128.26
(iv) Bank balances other than (iii) above 118.11 15.83
(v) Loans 25.01 14.39
(vi) Other financial assets 802.47 247.77
(c) Other current assets
Total current assets
7,854.86
1,42,506.79
8,076.16
1,25,240.28
Total assets 1,89,814.56 I, 71,921.68
(a) EQUITY AND LIABILITIES
EQUITY
Equity share capital
2,909.78 2,959.78
(b) Other equity 1,05,549.60 98,211.89
Total equity 1,08,459.38 l,0l,171.67
LIABILITIES
(I} Non-current liabilities
(a) Financial liabilities
(i) Borrowings
(ii) Lease liabilities
2,347.24
264.60
2,917.16
(b) Provisions 550.26 231.35
218.42
(c) Deferred tax liabilities (Net) 443.08 1,00 1.75
Total non-current liabilities 3,605. 18 4,368.68
Current liabilities
(2) (a) Financial liabilities
(i) Borrowings 7,614.99 5,402.73
(ii) Lease liabilities 239.54 179.70
(iii) Trade Payables
(A) total outstanding due of micro enterprises and small
enterprises; and
2,268.36 1,776.72
(B) total outstanding dues of creditors other than micro
enterprises and small enterprises. 48,506.08 40,184.34
(iv) Other financial liabilities 4,692.77 4, 133.86
(b) Other current liabilities
(c) Provisions
13,064.38 14,292.77
(d) Current tax liabilities (Net) 483.82
880.06
411.21
Total current liabilities 77,750.00 66,381.33
Total equity and liabilities 1,89,814.56 1,71,921.68
• Restated B.

~5 Ra~·esh umar Aggarwal Place: Delhi ~ .. OEL'f\'" na~ng Director Date: May 28, 2025 DIN : 00576872

" ~ • ~ y

Insecticides (India) Limited
CIN: L6599IDL1996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - I 10 033;
Telefax.: 01 1-27679700 - 05; Website: www.insecticidesindia.com; E-mail: [email protected]
,-
CONSOLIDATED AUDITED STATEMENT OF CASH FLOW FOR THE YEAR ENDED MARCH 31, 2025
(fin lacs)
Particulars 31-03-2025 31-03-2024 •
(A) Cash Flow From Operating Activities
Profit before tax 19,276.94 13,188.81
Adjustment on account of
- Share of Net Profit of Jointly controlled entity (57.45) (31.02)
- Depreciation 2,915.34 2,925.37
- (Profit)/ Loss on sale of property, plant & equipment (I 9.09) (173.23)
- Net gain on lease modification - (0.27)
- Interest income (235.51) (52.85)
- Dividend income (22.83) (22.05)
- Interest expenses 686.45 1,088.83
- Bad debts written off 29.26 22.76
- Loss Allowance on Advances 217.83 -
- Provision for impairment of trade receivables 554.65 272.20
- Gain on investment (5.16) (5.04)
- Derivative (gain)/ loss 270.90 20.88
- Unrealised exchange differences (290 15 (153.98'
Operating Profit Before Working Capital Changes 23,321.18 17,080.41
Adjustments for
- (lncreasc)/Decrease in security deposits (30.72) (37.36)
- (Jncrease)/Decrease in inventories (7,886.27) 5,433.79
- (lncrease)/Decrease in trade receivables (9,398.04) (253.67)
- (lncreasc)/Decrease in loans (JO 62) 4.84
- (lncrcase)/Decrcase in other financial assets (71 4.74) (179.55)
- (Jncrease)/Decrease in other current assets 398.40 (2,7 14.89)
- lncrease/(Decreasc) in provisions 264.94 194.50
- lncrease/(Decrease) in trade payables
- lncrcasc/(Decrease) in other financial liabilities
9,105.41
(295.22)
(2,741.01)
- lncrease/(Decrease) in other current liabilities (I 228.40 832.78
2,428.29
Cash generated from operations 13,525.92 20,048.13
Less: Income tax oaid (4,180.23) (1,350.23
Net cash flow (used in) / from operating activities (A) 9,345.69 18,697.90
(B) Cash Flow From Investing Activities
- Purchase of property, plant and equipment and intangible assets, capital-work-in-progress and (4,903.61)
intangible assets under development (3,728.90)
- Proceeds from sale of property plant and equipment 261.87 535.97
- Interest received 235.5 1 52.85
- Proceeds from/ (investment in) bank deposits (net) 2.31 (7.69)
- Purchase of investment (80485) (700.00)
- Sale of investment 239.86 355.04
- Dividends received 22. 17 20.58
Net. cash now ( used in) / from Investing Activities (B) (3 772.03) (4,646.86)
(C) Cash Flow From Financing Activities
- Repayment due to Buyback of equity shares including premium, expenses & taxes (6,188.02) -
- Repayment of non-current borrowings (1,331.12) (1,794.09)
- Proceeds from non-current borrowings 708.59 4,470.23
- Proceeds/(Repayment) from/of current borrowings 2,212.25 ( I 0,318.30)
- Payment of lease liabilities (220.4 1) (178.99)
- Interest paid (698.55) (1,096.75)
- Dividend paid (Final & Interim) (591.96 (887.94
Net cash flow (used in)/ from fi
nancing activities (C)
(6,109.22' (9,805.84
Net increase/ {decrease) in Cash and Cash Equivalents {A+B+C)
Cash and Cash Eouivalents at the be11.innine. of the year (535.56)
6 128.26
4,245.20
I 883.06
Cash and Cash Equivalents at the end of the vear 5,592.70 6,128.26
• Restated
\'.::r ,
For and on behalf of the Board of Directors
S ., O•dl•) Limi"
d
~
~
t;
~
r
uJ
c'
~
Rajesj umar Aggarwal
00
Place: Delhi
/"DEL-\*
RnAging Director

~c' Rajesj umar Aggarwal Place: Delhi /"DEL-\* RnAging Director Date: May 28, 2025 DIN : 00576872

S S KOTHARI MEHTA

& CO. LLP

Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-lll

Chartered Accountants 675, Aggarnal Cyber Plaza-2,

Independent Auditor's Report on the Quarterly and Year ended Audited Consolidated Financial Results of Insecticides (India) Limited Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended

To

The Board of Directors of Insecticides (India) Limited

Report on the audit of the Consolidated Financial Results

Opinion

We have audited the accompanying statement of quarterly and year to date Consolidated Financial Results of Insecticides (India) Limited (hereinafter referred to as the "Holding Company"), its subsidiaries (Holding Company and its subsidiaries together referred to as "the Group') and its share of net profit/(loss) after tax and totalcomprehensive income/(loss) of its joint\$ controlled entity for the quarter andyear ended March 31, 2025("statemenf'), attached herewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations").

In our opinion and to the best of our information and according to the explanations given to us, and based on the consideration of the audit reports of the other auditors on financial statements/financial information of a subsidiaries and its jointly controlled Entity referred to in Other Matters section below, the Statement:

a. includes the results of the following entities

(i) Jointly Controlled Entity

  • OAT & IIL India Laboratories Private Limited

(ii) Subsidiary

  • [L Biologicals Limited
  • Kaeros Research Private Limited
  • IIL Overseas DMCC
  • b. is presented in accordance with the requirements of Regulation 33 of the Listing Regulations, as amended; and
  • c. givcs a ir.ue aid fair view in confonnity with thc rccognition and mcasurement principles laid dorm in the Indian Accounting Standards and other accounting principles generally accepted in India of the consolidated net profit and consolidated other comprehensive income/(loss) and other financial information of the Group for the quarter and year ended March 31,2025.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Companies Act,2013 (the Act)' Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Consolidated Financial Results' section of our report. We are independent ofthe Group and its jointly controlled entity in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit

S S KOTHARI MEHTA

& CO. LLP

Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-lll

Chartered Accountants 675, Aggarwal Cyber Plaza-Z,

of the financial statements under the provisions of the Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics.

We believe that the audit evidence obtained by us and other auditors in terms of their reports referred to in Other Matters section below, is sufficient and appropriate to provide a basis for our opinion.

Management's Responsibilities for the Consolidated Financial Results

The Statement, which is the responsibility of the Holding Company's management and has been approved by the Holding Company's Board of Directors, has been prepared on the basis of the consolidated annual frnancial statements. The Holding Company's Board of Directors are responsible for the preparation and presentation of the statement that give a true and fair view of the net profit and other comprehensive income and other financial information of the Group and its jointly controlled entity in accordance with the applicable accounting standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations.

The respective Board of Directors of the companies included in the Group and its jointly controlled entity, are r"rponsibl" for maintenance of adequate accounting records in accordance with the provisions of the Act, for safiguarding ofthe assets ofthe Group and itsjointly controlled entity and forpreventing and detecting frauds and other inegularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate intemal financial controls, that were operating effectively, for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation ofthe financial results, that give a true and fair view ind are free from material misstatement, whether due to fraud or error which have been used for the purpose of preparation of the Statement by the Directors of the Holding Company, as aforesaid.

In preparing the Statement, the respective Board of Directors of the companies included in the Group and of its jointly controlled entity are responsible for assessing the ability of the Group and of its jointly controlled entity to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis oi accounting, unless the respective Board of Directors either intends to liquidate the Group or to cease operations, or has no realistic altemative but to do so.

The respective Board of Directors of the companies included in the Group and of its jointly controlled entity are responsible for overseeing the financial reporting process of their respective companies.

Auditor's Responsibilities for the Audit of the Consolidated Financial Results

Our objectives are to obtain reasonable assurance about whether the statement as a whole are free from material misstatement, whether due to f?aud or etror, anci to issue an auditor's report thai includes our opiniou. Reasonable assurance is a high level ofassurance but is not a guarantee that an audit conducted in accordance with SAs will always detecia material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if; individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the Statement.

As part of an audit in accordance rvith SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identiff and assess the risks of material misstatement design and perform audit procedures responsive to sufficient and appropriate to provide a basis for our of the statement, whether due to fraud or error, those risks, and obtain audit evidence that is opinion. The risk of not detecting a material a

S S KOTHARI MEHTA DEVESH PAREKH & CO.

& CO. LLP

Chartered Accountants Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-lll 675, Aggarwal Cyber Plaza-2, N.ew Delhi -110020 . Netaji Subhash Place.Pitampura. Dqlhi-110034

misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of intemal control.

  • Obtain an understanding of intemal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, Under Section 143(3Xi) of the Act, we are also responsible for expressing our opinion through a separate report on the complete set of financial statements on whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness ofsuch controls. a
  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors' a
  • Conclude on the appropriateness of the Board of Directors' use of the going concem basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group and of its jointly controlled entity to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the statement or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its jointly controlled entity to cease to continue as a going concem. a
  • Evaluate the overall presentation, structure and content ofthe consolidated financial results, including the discloswes, and whether the statement represent the underlying transactions and events in a manner that achieves fair presentation. a
  • e Obtain sufficient appropriate audit evidence regarding the financial results/financial information of theentitywithintheGroupandofitsjointlycontrolledentityofwhichwe aretheindependentauditors and whose financials information we have audited, to express an opinion on the Statement' We are responsible for the direction; supervision and performance of the audit of financial information of such entity included in the Statement of which we are the independent auditors. For the other entities included in the Statement, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion'

We communicate with those charged with governance of the Holding Company regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in intemal control that we identi\$ during our audit'

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding ind-pendence, and to communicate with them all relationships and other matters that -uy rru.ooublyle thought t-o bear on our independence, and where applicable, related safeguards'

We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the Listing Regulations, as amended, to the extent applicable'

S S KOTHARI MEHTA & co. tLP Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-lll

Chartered Accountants 675, Aggarwal CYber Plaza-2,

Other Matters

  1. The accompanying Statement includes the audited financial statements, in respect of:

  2. (a) 2 subsidiaries, whose audited financial statement reflects total assets of Rs. 2,425.55 lakhs as at March 3l, Zlzs,total revenue of Rs. 632.?3 Lakhs and Rs. 3,443.33 Lakhs, total net profit/(loss) after tax of Rs. 13,35 lakhs and Fis.242.63lakhs, total comprehensive income/(loss) of Rs. 13.35 lakhs and Rs' Z4Z.63Lakhs for the quarter and year ended March 3l,z)zs,respectively and net cash flows of Rs' 34.03 lakhs for the yel ended onthat date, as considered in the Statement which have been audited by one of the joint auditors, individually'

  3. ft) The Statement includes the Holding Company's share of net profit/(loss) after tax of Rs. 0'43 lakfrs and Rs. 57.45 lakhs and total comprehensive income/(loss) of Rs' 3.91 lakhs and Rs. 51'27 lakhs for the quarter and year ended March 3l,z}2s,respectively, as considered in the statement, in respect of jointly controlled entity. These financial statements are audited by other auditors.

The reports on the audited financial statements of these entities have been furnished to us by the management and our opinion on the Statement, in so far as itrelates to the amounts and disclosures included inr"sie"tofsubsidiat'unJ:ointfvcontrolled entlty,isbasedsolelyon thereportsofslgnauditorsandthe pro."i*., perfor-ed by u, u." as stated under Auditor's Responsibilities for the Audit of the Statement section above.

Our opinion on the Statement, is not modified in respect of the above matters with respect to our reliance on the work done and the reports of such auditors'

  1. The accompanying Statement includes the unaudited financial information, in respect of a foreign subsidiary, whose unaudited financial information reflect total assets of Rs' 4'16 Lakhs as at March 31, 2025, totalrevenue of Rs. Nil and Rs. NIL, total net profiV (loss) after tax Rs. NIL and Rs. (6.aQ Lakhs, total comprehensive income/(loss) of Rs. 1fi.Ol; faHts ana ni'-1e '+e) Lakhs for the quarter and year ended March 3l , z0z5,."rp."tiu"ty, ani net flo*, Rs. Nil for the year ended on that date, as considered in the Statement.

These financial information are unaudited and have been fumished to us by the management and 9u1 opinion on the consolidated financial results, in so far as it relates to the amounts and disclosures included in respect of said subsidiary, is based sole( on such unaudited financial statements. In our opinion and according to the information und explanaiions given to us by the Board of Directors, these financial statements are not material to the Group.

Our opinion on the Statement, is not modified in respect of the above rlraltcrs witli respeci to our rcliance on the financial information certified by the Board of Directors.

  1. We draw attention to Note no. 6 to the accompanying Statement, in respect of purchase of shares of Target company tom its "xisting shareholders through a share purchase agreement between the existing shareholders and the Com[any. This transactio-n has been accounted under 'the pooling of interests method, i.e. in accordurr"" *ith Appendix C of IND AS 103 'Business Combination" In vielv of the above and in terms of th; 6;;;entsirnder applicable Ind AS, the previous period I yeat figures have been restated.

our opinion on the statement is not modified in respect of the above maltet

S S KOTHARI MEHTA & CO. LLP

Chartered Accountants Plot No. 68, Okhla Industrial Area, Phase-III DEVESH PAREKH & CO.

Chartered Accountants 675, Aggarwal Cyber Plaza-2,

4 The Statement includes the results for the quarter ended March 31,2025 being the balancing figure between the audited figures in respect of the fuil financial year ended March 31,2025 and the published unaudited year to date frgures upto the end of third quarter of the current financial year, which were subjected to limited review by us, as required under the listing Regulations.

For S S Kothari Mehta & Co. LLP Chartered Accountants Firm's regisffation number:000756N4I50044 I

a i

Parhrer Membership number: UDIN: 2509267 IB]|I{OF CG97 9 6

Place: Delhi Date: 28ft May 2025

For Devesh Parekh & Co. Chartered Accountants Firm's registration number: 0 13338N

Parbrer * hi Vijay Kumar

Membership number: 527 87 3 UDIN: 255278738NUICB8 929

Place: Delhi Date:28'hMay 2025

Ref : IIL/SE/2025/2805/2 Dated : May 28, 2025

Listing Compliance Department Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
(Through BSE Listing Centre) (Through NEAPS)
Serio Code: 532851 Symbol: INSECTICID

Dear Sir/Madam,

Sub: Declaration on the Auditor's Report with Unmodified opinion under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

I, Sandeep Aggarwal, Chief Financial Officer of the Company, in compliance with Regulation 33(3)(d) ofSEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 hereby declare that Joint Statutory Auditors of the Company i.e. S S Kothari Mehta & Co., LLP (Firm Registration No. 000756N) and Devesh Parekh & Co., (Firm Registration No. 013338N) have issued the Audit report with unmodified opinion in respect of the Audited Financial Results (Standalone and Consolidated) of the Company for the Financial Year ended on March 31 , 2025.

This is for your information on records.

Thanking you,

Yours Truly, Forited

(Sandee Aggarwal) Chief Financial Officer Mem No. : 90189

Details as required in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024.

S. No. Details of events that need to be Description
provided
1. Reason
for
change
viz.
appointment,
re-appointment,
resignation,
removal,
death
or
otherwise
Appointment
of
M/s.
Akash
Gupta
&
Associates,
Peer
Reviewed
Company
Secretaries (PCS Registration No. 11038), as
Secretarial Auditor of the Company for a
period of five consecutive years commencing
from financial year 2025-26 till financial year
2029-30, subject to approval of members at the
ensuing 28th AGM, in compliance with the
amended
Regulation
24A
of
the
Listing
Regulations.
2. Date
of
appointment/
reappointment/
cessation
(as
applicable)
&
term
of
appointment/ re-appointment
Refer response to point (1) above.
3. Brief
Profile
(in
case
of
appointment)
M/s. Akash Gupta and Associates is a reputed
firm
of
Practicing
Company
Secretaries,
founded
by
Mr.
Akash
Gupta,
a
Fellow
Member
of
the
Institute
of
Company
Secretaries
of
India
(ICSI)
having
an
experience of around 13 years. Guided by Mr.
Gupta's extensive experience and leadership in
corporate governance, the firm has become a
trusted name in the field of compliance and
advisory services.
Backed by a team of highly qualified and
experienced professionals, the firm is known
for
its
commitment
to
integrity,
technical
excellence, and client-centric approach. Over
the years, Akash Gupta and Associates has
built a diverse and growing client base, serving
businesses across sectors and geographies.
The firm offers a comprehensive range of

services, including secretarial audits, corporate
governance
consulting,
regulatory
certifications, and advisory on corporate and
securities laws. These services are tailored to
support clients in ensuring legal compliance,
enhancing
transparency,
and
strengthening
their governance frameworks.
4. Disclosure
of
relationships
between
directors
(in
case
of
appointment of a director)
Not Applicable